NASDAQ:OPK - Opko Health News Headlines

$2.27
+0.10 (+4.61 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$2.1550
Now: $2.27
$2.30
50-Day Range
$1.78
MA: $1.93
$2.27
52-Week Range
$1.73
Now: $2.27
$4.61
Volume3.86 million shs
Average Volume4.54 million shs
Market Capitalization$1.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.19

Headlines

Opko Health (NASDAQ OPK) News Headlines

Source:
DateHeadline
November 1st Options Now Available For OPKO Health (OPK)November 1st Options Now Available For OPKO Health (OPK)
www.nasdaq.com - September 13 at 1:27 PM
Opko Healths (OPK) "Buy" Rating Reiterated at Barrington ResearchOpko Health's (OPK) "Buy" Rating Reiterated at Barrington Research
www.americanbankingnews.com - September 12 at 1:23 PM
Why Is OPKO Health (OPK) Down 2.6% Since Last Earnings Report?Why Is OPKO Health (OPK) Down 2.6% Since Last Earnings Report?
finance.yahoo.com - September 7 at 10:23 AM
October 11th Options Now Available For OPKO Health (OPK)October 11th Options Now Available For OPKO Health (OPK)
www.nasdaq.com - September 3 at 3:05 PM
Is OPKO Health (NASDAQ:OPK) A Risky Investment?Is OPKO Health (NASDAQ:OPK) A Risky Investment?
finance.yahoo.com - September 3 at 3:05 PM
Opko Health Inc. (NASDAQ:OPK) Expected to Announce Quarterly Sales of $224.55 MillionOpko Health Inc. (NASDAQ:OPK) Expected to Announce Quarterly Sales of $224.55 Million
www.americanbankingnews.com - September 1 at 1:38 AM
Opko Health Inc. (NASDAQ:OPK) Expected to Announce Earnings of -$0.10 Per ShareOpko Health Inc. (NASDAQ:OPK) Expected to Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - August 30 at 6:20 PM
Opko Health completes late-stage somatrogon studyOpko Health completes late-stage somatrogon study
seekingalpha.com - August 29 at 3:07 PM
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone DeficiencyOPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency
finance.yahoo.com - August 29 at 9:32 AM
Smart Inhalers Market 2024 Key Players- Adherium Limited, Vectura Group plc, AstraZeneca plc, Cohero Health, LLC, Propeller HealthSmart Inhalers Market 2024 Key Players- Adherium Limited, Vectura Group plc, AstraZeneca plc, Cohero Health, LLC, Propeller Health
www.marketwatch.com - August 26 at 5:17 AM
Digital Dose Inhaler Market Latest Innovations with Key Players Glenmark Pharmaceuticals, Novartis, Propeller Health, AstraZenecaDigital Dose Inhaler Market Latest Innovations with Key Players Glenmark Pharmaceuticals, Novartis, Propeller Health, AstraZeneca
www.marketwatch.com - August 19 at 3:14 PM
Edited Transcript of OPK earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of OPK earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 19 at 3:14 PM
Clinical Laboratory Services Market Size is Continues to Grow US$330 Billion By 2026Clinical Laboratory Services Market Size is Continues to Grow US$330 Billion By 2026
www.marketwatch.com - August 14 at 3:14 PM
Cancer Drug Sales Expected to Exceed $230 Billion by 2024Cancer Drug Sales Expected to Exceed $230 Billion by 2024
www.marketwatch.com - August 13 at 9:49 AM
Increasing Indoor and Outdoor Pollution to Boost the Growth of Global Smart Pediatric Inhalers MarketIncreasing Indoor and Outdoor Pollution to Boost the Growth of Global Smart Pediatric Inhalers Market
www.marketwatch.com - August 9 at 11:55 AM
Opko Health (OPK) Q2 2019 Earnings Call TranscriptOpko Health (OPK) Q2 2019 Earnings Call Transcript
www.fool.com - August 8 at 11:30 AM
OPKO Q2 top line down 14% but above views; shares ahead 4% after hoursOPKO Q2 top line down 14% but above views; shares ahead 4% after hours
seekingalpha.com - August 7 at 9:47 PM
OPKO Health Reports 2019 Second Quarter Business Highlights and Financial ResultsOPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results
www.nasdaq.com - August 7 at 9:47 PM
BRIEF-Opko Health Says Qtrly Loss Per Share $0.10BRIEF-Opko Health Says Qtrly Loss Per Share $0.10
www.msn.com - August 7 at 9:47 PM
OPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2019 Results - Earnings Call TranscriptOPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 9:47 PM
A Preview Of Opko Healths Q2 EarningsA Preview Of Opko Health's Q2 Earnings
www.benzinga.com - August 7 at 11:29 AM
OPKO Health Q2 2019 Earnings PreviewOPKO Health Q2 2019 Earnings Preview
seekingalpha.com - August 6 at 8:34 PM
OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019
finance.yahoo.com - August 1 at 3:18 PM
BIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER BY THE IPA ASSOCIATION OF AMERICABIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER BY THE IPA ASSOCIATION OF AMERICA
finance.yahoo.com - August 1 at 8:05 AM
Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to DeclineEarnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline
finance.yahoo.com - July 30 at 3:25 PM
BRIEF-Opko Health And CEO Phillip Frost Release Joint Statement Regarding Frosts Recent HospitalizationBRIEF-Opko Health And CEO Phillip Frost Release Joint Statement Regarding Frost's Recent Hospitalization
www.msn.com - July 30 at 5:42 AM
Smart Inhalers Market Expands At CAGR 58.4% by 2026 Available In New ReportSmart Inhalers Market Expands At CAGR 58.4% by 2026 Available In New Report
www.marketwatch.com - July 29 at 11:15 AM
Is OPKO Health, Inc.'s (NASDAQ:OPK) CEO Pay Fair?Is OPKO Health, Inc.'s (NASDAQ:OPK) CEO Pay Fair?
finance.yahoo.com - July 29 at 11:15 AM
First Week of March 2020 Options Trading For OPKO Health Inc (OPK)First Week of March 2020 Options Trading For OPKO Health Inc (OPK)
www.nasdaq.com - July 23 at 3:15 PM
Hormone Replacement Therapy Market to Exhibit Ravishing Growth By 2026Hormone Replacement Therapy Market to Exhibit Ravishing Growth By 2026
www.marketwatch.com - July 13 at 5:35 AM
Why OPKO Health Stock Jumped TodayWhy OPKO Health Stock Jumped Today
finance.yahoo.com - June 29 at 5:49 AM
Here’s What Hedge Funds Think About Opko Health Inc. (OPK)Here’s What Hedge Funds Think About Opko Health Inc. (OPK)
finance.yahoo.com - June 29 at 5:49 AM
Opko scores win for 4KscoreOpko scores win for 4Kscore
www.bizjournals.com - June 28 at 3:17 PM
Novitas issues LCD for the 4kscore testNovitas issues LCD for the 4kscore test
seekingalpha.com - June 28 at 3:17 PM
Novitas Issues Proposed Local Coverage Determination for the 4Kscore® TestNovitas Issues Proposed Local Coverage Determination for the 4Kscore® Test
finance.yahoo.com - June 28 at 3:17 PM
Ventures Roundup: 3 questions with Secocha Ventures; Opko requests FDA approval of 4KScoreVentures Roundup: 3 questions with Secocha Ventures; Opko requests FDA approval of 4KScore
www.bizjournals.com - June 27 at 3:01 PM
Pressure builds to secure health care dataPressure builds to secure health care data
www.msn.com - June 27 at 5:06 AM
OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® TestOPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test
finance.yahoo.com - June 20 at 9:18 AM
South Florida businessman accused of $27M penny stock fraud agrees to proposed judgmentSouth Florida businessman accused of $27M penny stock fraud agrees to proposed judgment
finance.yahoo.com - June 18 at 5:00 PM
More Medical Mega-Breaches Thanks To Third-Party InsecurityMore Medical Mega-Breaches Thanks To Third-Party Insecurity
www.forbes.com - June 14 at 3:18 PM
Healthy Growth and New Biosimilar Approvals by Human Growth Hormone Market 2019Healthy Growth and New Biosimilar Approvals by Human Growth Hormone Market 2019
www.marketwatch.com - June 13 at 11:59 AM
BioReference Laboratories Supports Man Cave Health During National Men’s Health MonthBioReference Laboratories Supports Man Cave Health During National Men’s Health Month
finance.yahoo.com - June 7 at 4:20 PM
Opko Health says over 400,000 customers likely affected by data breachOpko Health says over 400,000 customers likely affected by data breach
www.reuters.com - June 7 at 5:02 AM
UPDATE 1-Opko Health says over 400,000 customers likely affected by data breachUPDATE 1-Opko Health says over 400,000 customers likely affected by data breach
finance.yahoo.com - June 6 at 3:14 PM
Why Is OPKO Health (OPK) Down 6.7% Since Last Earnings Report?Why Is OPKO Health (OPK) Down 6.7% Since Last Earnings Report?
finance.yahoo.com - June 6 at 3:14 PM
Esoteric Testing Market is Anticipated to Reach US$ 35 Billion by 2024Esoteric Testing Market is Anticipated to Reach US$ 35 Billion by 2024
www.marketwatch.com - May 30 at 3:13 PM
When Will OPKO Health, Inc. (NASDAQ:OPK) Turn A Profit?When Will OPKO Health, Inc. (NASDAQ:OPK) Turn A Profit?
finance.yahoo.com - May 30 at 3:13 PM
Interesting OPK Call Options For July 5thInteresting OPK Call Options For July 5th
www.nasdaq.com - May 23 at 3:11 PM
Aerobic Vaginitis (AV) Testing Now Available At BioReference LaboratoriesAerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories
finance.yahoo.com - May 17 at 3:06 PM
Why Opko Health Stock Sank TodayWhy Opko Health Stock Sank Today
www.nasdaq.com - May 17 at 5:20 AM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel